These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 9317076)
1. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. Moriyama A; Masumoto A; Nanri H; Tabaru A; Unoki H; Imoto I; Ikeda M; Otsuki M Am J Gastroenterol; 1997 Sep; 92(9):1520-3. PubMed ID: 9317076 [TBL] [Abstract][Full Text] [Related]
2. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375 [TBL] [Abstract][Full Text] [Related]
3. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Guarner C; Soriano G; Tomas A; Bulbena O; Novella MT; Balanzo J; Vilardell F; Mourelle M; Moncada S Hepatology; 1993 Nov; 18(5):1139-43. PubMed ID: 8225220 [TBL] [Abstract][Full Text] [Related]
4. Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma: relationship with clinical factors and prognostic importance during therapy. Yamauchi K; Akbar SM; Horiike N; Michitaka K; Onji M Int J Mol Med; 2003 May; 11(5):601-5. PubMed ID: 12684696 [TBL] [Abstract][Full Text] [Related]
5. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma. Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462 [TBL] [Abstract][Full Text] [Related]
6. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846 [TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma. Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268 [TBL] [Abstract][Full Text] [Related]
8. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma. Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813 [TBL] [Abstract][Full Text] [Related]
9. Higher serum nitrate levels are associated with poor survival in lung cancer patients. Colakogullari M; Ulukaya E; Yilmaztepe A; Ocakoglu G; Yilmaz M; Karadag M; Tokullugil A Clin Biochem; 2006 Sep; 39(9):898-903. PubMed ID: 16919616 [TBL] [Abstract][Full Text] [Related]
14. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Marrero JA; Su GL; Wei W; Emick D; Conjeevaram HS; Fontana RJ; Lok AS Hepatology; 2003 May; 37(5):1114-21. PubMed ID: 12717392 [TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients]. Zhou Q; Liang LJ; Peng BG; Zhen YY Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916 [TBL] [Abstract][Full Text] [Related]
16. Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma. Moriyama A; Tabaru A; Unoki H; Abe S; Masumoto A; Otsuki M Clin Chim Acta; 2000 Jun; 296(1-2):181-91. PubMed ID: 10807981 [TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727 [TBL] [Abstract][Full Text] [Related]
18. Decreased hepatic nitric oxide synthesis during liver surgery. Ueda T; Sakabe T; Oka M; Maeda Y; Nishida M; Murakami F; Maekawa T Hepatogastroenterology; 1999; 46(27):1917-22. PubMed ID: 10430369 [TBL] [Abstract][Full Text] [Related]
19. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis. Henry L; Lavabre-Bertrand T; Vercambre L; Ramos J; Carillo S; Guiraud I; Pouderoux P; Bismuth M; Valats JC; Demattei C; Duny Y; Chaze I; Funakoshi N; Bureau JP; Daurès JP; Blanc P Gut; 2009 Jun; 58(6):833-8. PubMed ID: 19201777 [TBL] [Abstract][Full Text] [Related]
20. Serum erythropoietin measurements by a one-step sandwich enzyme linked immunosorbent assay in patients with hepatocellular carcinoma and liver cirrhosis. Sawabe Y; Iida S; Tabata Y; Yonemitsu H Jpn J Clin Oncol; 1993 Oct; 23(5):273-7. PubMed ID: 7693989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]